Latest HAL publications
- [hal-05399480] Color-Tunable Persistent Luminescence in Eu 2+ ,Dy 3+ ,B 3+ co-doped Sr 4 Al 14 O 25 and SrAl 2 O 4 Strontium...by ano.nymous@ccsd.cnrs.fr.invalid (Guanyu Cai) on 5 December 2025
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Persistent luminescent (PersL) materials have garnered significant attention for applications in signaling, bioimaging, and anti-counterfeiting due to their long lasting emission after […]
- [hal-05390034] Characterization and quantification of therapeutic monoclonal antibodies, anti-drug antibodies and their...by ano.nymous@ccsd.cnrs.fr.invalid (Lola Alez-Martin) on 3 December 2025
Therapeutic monoclonal antibodies (mAbs) are experiencing tremendous developments in terms of novel approved products and applications fields. Nonetheless, after administration, mAbs are submitted to a significant number of biological phenomena that […]
- [hal-05393790] A colorimetric supramolecular sensor array for anaesthetic drugs detection and classificationby ano.nymous@ccsd.cnrs.fr.invalid (Carlos Gonzalez-Galindo) on 2 December 2025
The global pharmaceutical industry has experienced significant growth, accompanied by a worrying increase in counterfeit medicines. Substandard medicines pose serious health risks, including poisoning, exacerbation of untreated conditions and […]
- [hal-05392740] ZGSO:Cr 3+ ,Ni 2+ Persistent Phosphors with Dual Emission in NIR‐I and SWIR Ranges for Bio‐Imaging Applicationsby ano.nymous@ccsd.cnrs.fr.invalid (Guanyu Cai) on 2 December 2025
Persistent luminescence (PersL) is widely used for near infrared (NIR‐I, 650–950 nm) imaging as they allow getting images without background. Bio‐imaging in the second shortwave‐infrared region SWIR‐II (NIR‐II, 1000–1400 nm) is less […]
- [tel-05381306] Nanoformulations d'agents antioxydants à visée ophtalmique pour la prévention de la dégénérescence maculaire...by ano.nymous@ccsd.cnrs.fr.invalid (Mitta Pierre) on 25 November 2025
Introduction : la dégénérescence maculaire liée à l'âge (DMLA) est une maladie rétinienne cécitante où la dysrégulation du stress oxydatif joue un rôle majeur. L'étude AREDS (Age-Related Eye Disease Study), vaste essai clinique […]
- [hal-05376701] New Prospects for Therapeutic Organic Nanocrystalsby ano.nymous@ccsd.cnrs.fr.invalid (Matthieu Lamballe) on 21 November 2025
Nanocrystals have emerged as an interesting class of delivery systems for solubilizing pharmaceuticals in classes II and IV of the Biopharmaceutics Classification System (BCS) † . This can be attributed to their small size and high drug content. […]
- [hal-05368740] IgG detection in human serum employing non-functionalized chromium doped zinc gallate nanoparticlesby ano.nymous@ccsd.cnrs.fr.invalid (Zied Ferjaoui) on 17 November 2025
Chromium-doped zinc gallate (ZnGa2O4:Cr3 +) nanoparticles (ZGO) show promising potential for antigen immunodetection using persistent luminescence, thereby reducing autofluorescence interference. Recently, we have shown that ZGO prepared by […]
- [hal-05352187] Liposomal Combination Therapy in Pancreatic Cancer: A Study on Potential Synergistic Effectsby ano.nymous@ccsd.cnrs.fr.invalid (Valeria Bincoletto) on 6 November 2025
<div><p>Pancreatic ductal adenocarcinoma is an aggressive and often fatal cancer, primarily due to its insidious progression and the lack of effective screening tools, which frequently result in late-stage diagnosis 1 . For many years, […]
- [hal-05352127] Fluorescent Nanodiamond-based delivery systems for mitochondrial targeting of bioactive moleculesby ano.nymous@ccsd.cnrs.fr.invalid (Dorna Akbarzadeh) on 6 November 2025
[...]
- [hal-05338667] Multifunctional nanoparticles to fight hormone-resistant prostate cancerby ano.nymous@ccsd.cnrs.fr.invalid (Killian Laguerre) on 6 November 2025
[...]
- [hal-05053933] Gemcitabine-monophosphate encapsulation in “stealth” MOFs effectively inhibits tumor growth in vivoby ano.nymous@ccsd.cnrs.fr.invalid (Killian Laguerre) on 6 November 2025
Gemcitabine is a commonly used chemotherapeutic agent that faces limitations due to rapid clearance, limited stability, and significant adverse effects. Recent efforts in its nanoencapsulation within Metal Organic Frameworks (MOFs) aim to overcome […]
- [hal-05349486] ANTITUMORAL EFFECT ON LIVER CANCER OF A TUMOR PENETRATING AND INTERFERING PEPTIDEby ano.nymous@ccsd.cnrs.fr.invalid (Eric Savier) on 5 November 2025
Hepatocellular carcinoma is one of the most frequent cancers in the world. Treatments such as immune checkpoint inhibitors or tyrosine kinase inhibitors (TKI) have some efficacy but have many adverse effects. So, more specifically targeted therapies […]